Alnylam Pharmaceuticals, Inc.
2014 Q1 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 63,853 | 0.2% | 160,577 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 162,704 | 0.5% | 356,806 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 2,512 | 0.0% | 7,702 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 16,823 | 0.1% | 62,302 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 3,948 | 0.0% | 16,776 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 53,424 | 0.2% | 194,247 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,612 | 0.0% | 14,863 | 6/30/2024 |
| 2023 Q3 | 11/14/2023 | 6,626 | 0.0% | 37,412 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 14,219 | 0.1% | 74,858 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 28,323 | 0.1% | 141,388 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 49,909 | 0.3% | 210,011 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 14,317 | 0.1% | 71,530 | 9/30/2022 |
| 2022 Q1 | 5/16/2022 | 4,797 | 0.0% | 29,380 | 3/31/2022 |
| 2021 Q3 | 11/15/2021 | 2,361 | 0.0% | 12,506 | 9/30/2021 |
| 2019 Q4 | 2/14/2020 | 4,424 | 0.1% | 38,410 | 12/31/2019 |
| 2014 Q1 | 5/9/2014 | 597 | 0.1% | 8,898 | 3/31/2014 |